Chen et al. (2015) found that abnormal expression of GOLM1 increased the proliferation and progression of hepatocellular carcinoma both in vitro and in vivo. Furthermore, the prognostic value of GOLM1 in predicting overall survival and recurrence-free survival among hepatocellular carcinoma patients was also proven (Mao et al., 2010; Bao et al., 2013). Moreover, the oncogenic role and prognostic value of GOLM1 in non-small-cell lung cancer were identified (Zhang et al., 2010; Zhang et al., 2017b). Here, GOLM1 is linked to non-small cell lung carcinoma.